Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
HMP.TO 0.03SPGP 1ZUQ.TO 0.55NVDA 0.32GL 1.66MRK -1.71IEMG 0.5GEV 33.87
Novelion (NVLN.TO)
The ultimate 360° Tracker Your financial life in one place, automatically

Novelion (NVLN.TO)

0.00
-0.00 (0.00%)
52 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
BUY

Novelion(NVLN.TO)

Feb 05, 2002
Under pressure. Sales not up to expectations. A good price and a good long term hold.
Photo of Mark Jackson, CFAMark Jackson, CFAUnlock Rating
$30.60

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Jan 24, 2002
Earnings should be reasonably good. Should have a good gain.
Photo of Brendan KyneBrendan KyneUnlock Rating
$36.80

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Jan 22, 2002
At a good level. New management. Have just lost one of their competitors.
Photo of John ZechnerJohn ZechnerUnlock Rating
$36.95

Stock price when the opinion was issued

biotechnologypharmaceutical
PAST TOP PICK

Novelion(NVLN.TO)

Jan 14, 2002
(Was a top pick on Oct 22 down 1%) Still likes. A competitor missed on a phase 3 trial.
Photo of Ted MacklinTed MacklinUnlock Rating
$38.20

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Jan 10, 2002
A great product for the eyes. Very highly priced, but a good buy.
Photo of Richard StoneRichard StoneUnlock Rating
$40.50

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Jan 03, 2002
Could be a takeover candidate. Good management.
Photo of David BaskinDavid BaskinUnlock Rating
$38.65

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Novelion(NVLN.TO)

Dec 10, 2001
Got approval of Visodine. Good valuation.
Photo of John ZechnerJohn ZechnerUnlock Rating
$36.50

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Dec 06, 2001
A one product company, but its a tremendous product.
Photo of Ted MacklinTed MacklinUnlock Rating
$35.94

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Novelion(NVLN.TO)

Dec 05, 2001
(Was a top pick on Aug 24 up 5%) Still likes. Their Visodine product is excellent and should do well through the years.
Photo of Martin Hubbes, CFAMartin Hubbes, CFAUnlock Rating
$36.14

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Nov 20, 2001
Biotechs are speculative. Have to buy a basket of them to be safe.
Photo of David BaskinDavid BaskinUnlock Rating
$32.00

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY ON WEAKNESS

Novelion(NVLN.TO)

Nov 15, 2001
Good product line. Could go higher. Would buy at $30.
Photo of Richard StoneRichard StoneUnlock Rating
$31.30

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY ON WEAKNESS

Novelion(NVLN.TO)

Oct 29, 2001
Could have good growth. Relatively safe. Buy on weakness.
Photo of Bruce Campbell (1)Bruce Campbell (1)Unlock Rating
$34.65

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY ON WEAKNESS

Novelion(NVLN.TO)

Oct 24, 2001
Fully valued. Has some winning products. Volatile.
Photo of David BaskinDavid BaskinUnlock Rating
$37.35

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Oct 23, 2001
Good company, but only one product. Could be volatile.
Photo of Pierre BernardPierre BernardUnlock Rating
$37.15

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Novelion(NVLN.TO)

Oct 22, 2001
Just got approval for visodine.
Photo of Ted MacklinTed MacklinUnlock Rating
$40.00

Stock price when the opinion was issued

biotechnologypharmaceutical
Showing 121 to 135 of 190 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

EPD -0.03$37.25
ET 0.31$19.07
MAIR 0$
RKLB -12.39$102.39
SESG-O 0$

Today's Top Picks

HMP.TO 0.03$9.75
SPGP 1$120.39
ZUQ.TO 0.55$107.47
NVDA 0.32$205.19
GL 1.66$166.76

Popular Articles

Latest Sell Signals

PRGO 0.09$10.99
CBRS 0$
HAWK 0$
AVEX 0$
SWMR 0$

Most Recent Experts

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Richard Orrell

Richard Orrell

RN Croft Financial Group

Stockchase Insights

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Stan Wong

Private Wealth Management, ScotiaMcleod

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica